Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KTRA - Kintara Therapeutics Inc


IEX Last Trade
0.1873
-0.002   -0.961%

Share volume: 1,177,884
Last Updated: Fri 30 Aug 2024 09:58:10 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.19
0.00
-0.95%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
22%
Profitability 25%
Dept financing 9%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-17.13%
1 Month
-16.58%
3 Months
-41.10%
6 Months
84.30%
1 Year
-95.99%
2 Year
-97.59%
Key data
Stock price
$0.19
P/E Ratio 
0.00
DAY RANGE
$0.18 - N/A
EPS 
$0.00
52 WEEK RANGE
$0.08 - $4.92
52 WEEK CHANGE
-$0.96
MARKET CAP 
10.325 M
YIELD 
N/A
SHARES OUTSTANDING 
55.305 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-1.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,486,185
AVERAGE 30 VOLUME 
$1,675,200
Company detail
CEO: Saiid Zarrabian
Region: US
Website: https://www.kintara.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news